company background image
A331920 logo

Celemics KOSDAQ:A331920 Stock Report

Last Price

₩4.36k

Market Cap

₩35.6b

7D

-0.8%

1Y

6.1%

Updated

12 Oct, 2024

Data

Company Financials

Celemics, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Celemics
Historical stock prices
Current Share Price₩4,360.00
52 Week High₩10,400.00
52 Week Low₩2,745.00
Beta0.79
11 Month Change-4.80%
3 Month Change22.30%
1 Year Change6.08%
33 Year Change-73.17%
5 Year Changen/a
Change since IPO-83.10%

Recent News & Updates

Recent updates

Celemics (KOSDAQ:331920) Is Posting Solid Earnings, But It Is Not All Good News

Aug 26
Celemics (KOSDAQ:331920) Is Posting Solid Earnings, But It Is Not All Good News

We're Not Very Worried About Celemics' (KOSDAQ:331920) Cash Burn Rate

Jul 29
We're Not Very Worried About Celemics' (KOSDAQ:331920) Cash Burn Rate

Here's Why We're Not Too Worried About Celemics' (KOSDAQ:331920) Cash Burn Situation

Mar 28
Here's Why We're Not Too Worried About Celemics' (KOSDAQ:331920) Cash Burn Situation

What You Need To Know About Celemics, Inc.'s (KOSDAQ:331920) Investor Composition

Dec 17
What You Need To Know About Celemics, Inc.'s (KOSDAQ:331920) Investor Composition

Shareholder Returns

A331920KR Life SciencesKR Market
7D-0.8%3.9%0.9%
1Y6.1%46.0%3.8%

Return vs Industry: A331920 underperformed the KR Life Sciences industry which returned 46% over the past year.

Return vs Market: A331920 exceeded the KR Market which returned 3.8% over the past year.

Price Volatility

Is A331920's price volatile compared to industry and market?
A331920 volatility
A331920 Average Weekly Movement20.2%
Life Sciences Industry Average Movement9.9%
Market Average Movement6.8%
10% most volatile stocks in KR Market12.2%
10% least volatile stocks in KR Market3.6%

Stable Share Price: A331920's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A331920's weekly volatility has increased from 11% to 20% over the past year.

About the Company

FoundedEmployeesCEOWebsite
201039Young-hoon Leewww.celemics.com

Celemics, Inc. designs, manufactures, and distributes sequencing kits. The company offers BRCA, somatic mutation cancer, and hereditary cancer kits; and NGS Library preparation kits. It also provides customized target enrichment kit, next generation sequencing, NGS unit, and NGS-lab building consulting services.

Celemics, Inc. Fundamentals Summary

How do Celemics's earnings and revenue compare to its market cap?
A331920 fundamental statistics
Market cap₩35.60b
Earnings (TTM)₩11.01b
Revenue (TTM)₩6.08b

3.2x

P/E Ratio

5.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A331920 income statement (TTM)
Revenue₩6.08b
Cost of Revenue₩3.65b
Gross Profit₩2.43b
Other Expenses-₩8.58b
Earnings₩11.01b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.35k
Gross Margin39.98%
Net Profit Margin181.03%
Debt/Equity Ratio0%

How did A331920 perform over the long term?

See historical performance and comparison